| NRX-101 for Complicated Urinary Tract Infection (UTI) Including Pyelonephritis (NCT06128213) | NeuroRx, Inc. | 2024-03-31 |
| Zanubrutinib in Combination With Obinutuzumab (ZO) for Newly Diagnosed Follicular Lymphoma (NCT06553352) | The First Affiliated Hospital of Xiamen University | 2024-03-31 |
| PROPHYLAXIS OF GVH IN ELDERLY PATIENTS RECEIVING HAPLOIDENTICAL ALLOGENIC HEMATOPOIETIC STEM CELL TRASNPLANTATION USE OF A LOW DOSE ANTI-LYMPHOCYTIC SERUM (NCT06066255) | Institut Paoli-Calmettes | 2024-03-31 |
| NAC for Attenuation of COVID-19 Symptomatology (NCT05074121) | Cambridge Health Alliance | 2024-03-31 |
| A Trial of Cadonilimab Plus Regorafenib in Patients With Hepatocellular Carcinoma Who Failed Camrelizumab Combined With Apatinib (NCT06280105) | Meng Chao Hepatobiliary Hospital of Fujian Medical University | 2024-03-31 |
| Magrolimab Plus Intensive Chemotherapy in Newly Diagnosed AML or HR-MDS (NCT05829434) | Uwe Platzbecker | 2024-03-31 |
| Pleurodesis Using Hypertonic Glucose (NCT06293885) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2024-03-30 |
| Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors (NCT06690216) | Man Hu | 2024-03-30 |
| Atezolizumab and Bevacizumab With Photon Radiotherapy for Unresectable Hepatocellular Carcinoma (NCT06339424) | Chang Gung Memorial Hospital | 2024-03-30 |
| Efficacy and Safety of Intratumoral Injection of Recombinant Human Adenovirus Type 5 Combined With Tislelizumab and Lenvatinib in the Treatment of Advanced Hepatocellular Carcinoma (NCT06253598) | The First Affiliated Hospital of Bengbu Medical University | 2024-03-30 |
| Adibelimab, Famitinib and Chemotherapy for Advanced NSCLC After PD-1 Inhibitor Failure (NCT06336954) | Second Affiliated Hospital of Xi'an Jiaotong University | 2024-03-30 |
| Doxycycline in Type II Diabetes (NCT06329882) | Mostafa Bahaa | 2024-03-30 |
| Perioperative Adebrelimab and Chemotherapy in Esophageal and Esophagogastric Junction Carcinoma (NCT06198465) | Xijing Hospital | 2024-03-30 |
| Ethosomal Gel Bearing Losartan 5% for Keloid Treatment (NCT05893108) | Yuni Eka Anggraini | 2024-03-30 |
| Study of CM310 in Subjects With Seasonal Allergic Rhinitis (NCT06171074) | Keymed Biosciences Co.Ltd | 2024-03-30 |
| A Study of SSGJ-613 in Gout Subjects Initiating Urate-Lowering Treatment. (NCT06270225) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2024-03-30 |
| CVL237 Tablets for APDS/PASLI (NCT06293716) | Convalife (Shanghai) Co., Ltd. | 2024-03-30 |
| Utidelone (UTD1) Plus Capecitabine in Non-pCR TNBC After Neoadjuvant Therapy (NCT06385990) | Hunan Cancer Hospital | 2024-03-29 |
| NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial (NCT06066437) | M.D. Anderson Cancer Center | 2024-03-29 |
| A Dose-finding Study to Evaluate mRNA-3210 in Participants With Phenylketonuria (NCT06147856) | ModernaTX, Inc. | 2024-03-29 |
| IC14 (Atibuclimab) in Arrhythmogenic Cardiomyopathy (NCT06275893) | Implicit Bioscience | 2024-03-29 |
| Venetoclax, Rituximab and Nivolumab in Combination for the Treatment of Richter's Transformation Arising From Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (NCT06247540) | Northwestern University | 2024-03-29 |
| A Study to Evaluate the Efficacy and Safety of BIIB131 for Participants With Ischemic Stroke Between 4.5 and 24 Hours After Last Known Well (NCT05764122) | Biogen | 2024-03-29 |
| A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis (NCT06254950) | Takeda | 2024-03-29 |
| LXE408 for Treatment of Visceral Leishmaniasis in Ethiopia, a Proof of Concept Study (NCT05957978) | Drugs for Neglected Diseases | 2024-03-29 |
| Durvalumab/Tremelimumab in Neoadjuvant and Adjuvant Setting in Patients With HCC Treated by by Percutaneous Ablation Procedure (NCT06045975) | Assistance Publique - Hôpitaux de Paris | 2024-03-28 |
| Study of JK07 in Patients With Chronic Heart Failure (NCT06369298) | Salubris Biotherapeutics Inc | 2024-03-28 |
| Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial (NCT06067269) | Jonsson Comprehensive Cancer Center | 2024-03-28 |
| A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis (NCT05828069) | National Cancer Institute (NCI) | 2024-03-28 |
| The Efficacy of Fecal Microbiota Transplatation on Axial Spondyloarthritis Patients Resistant to Conventional Treatment (NCT05654753) | Assistance Publique - Hôpitaux de Paris | 2024-03-28 |
| A Study to Compare Uliledlimab Combined With Toripalimab, Toripalimab Monotherapy, and Pembrolizumab Monotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1- and CD73- Selected Non-Small Cell Lung Cancer (NCT06984588) | TJ Biopharma Co., Ltd. | 2024-03-28 |
| A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer (NCT06347705) | Memorial Sloan Kettering Cancer Center | 2024-03-28 |
| Spermatogonial Differentiation Via Testicular Organoid (NCT06841861) | CellARTs Inc. | 2024-03-28 |
| Safety and Efficacy of CD123-targeted CAR-NK for Relapsed/Refractory Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell Neoplasm (NCT06006403) | Chongqing Precision Biotech Co., Ltd | 2024-03-28 |
| A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005) (NCT06305767) | Merck Sharp & Dohme LLC | 2024-03-28 |
| CAPOX and PD-1 Antibody Combined With or Without Radiotherapy for MSS Locally Advanced Rectal Cancer (NCT06281405) | Fudan University | 2024-03-28 |
| A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam) (NCT06223360) | Alzheimer's Disease Cooperative Study (ADCS) | 2024-03-28 |
| A Study to Assess the Efficacy, Safety, and Tolerability of Oral NORA520 in Adults With Severe Postpartum Depression (NCT06285916) | TWi Biotechnology, Inc. | 2024-03-28 |
| FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis (NCT06286709) | University of Birmingham | 2024-03-27 |
| Safety, Tolerability, and Efficacy of mFOLFIRINOX ± BNT321 as Adjuvant Therapy Following Curative Resection in Patients With Pancreatic Adenocarcinoma (NCT06069778) | BioNTech SE | 2024-03-27 |
| 68Ga-NY104 PET/CT Guided Radiation Therapy in CcRCC. (NCT06613269) | Peking Union Medical College Hospital | 2024-03-27 |
| Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis (NCT06290934) | Gilead Sciences | 2024-03-27 |
| Anti-Platelets in Chronic Obstructive Pulmonary Disease (NCT05567562) | Brigham and Women's Hospital | 2024-03-27 |
| Study of INV-102 Ophthalmic Solution in Adults With Moderate to Severe Dry Eye Disease (NCT06370039) | Invirsa, Inc. | 2024-03-27 |
| Phase I Study of sss40 Injection for Moderate-to-Severe Bone Metastatic Cancer Pain (NCT07008703) | Shenyang Sunshine Pharmaceutical Co., LTD. | 2024-03-27 |
| A Study to Test Different Doses of BI 1569912 in People With Depression Who Take Anti-depressive Medicine (NCT06280235) | Boehringer Ingelheim | 2024-03-27 |
| NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) (NCT06239272) | St. Jude Children's Research Hospital | 2024-03-27 |
| Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts (NCT06491446) | Antiva Biosciences | 2024-03-27 |
| Study of ZG005 in Combination With Paclitaxel＋Platinum-based ± Bevacizumab in Patients With Advanced Cervical Carcinoma (NCT06241235) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2024-03-27 |
| 5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-abdominal Cancer Surgery: A Randomized Clinical Trial (NCT06232577) | M.D. Anderson Cancer Center | 2024-03-27 |
| Tiragolumab, Atezolizumab and Chemotherapy in Triple Negative Breast Cancer (NCT06175390) | Institut Curie | 2024-03-27 |
| Phase II Clinical Trial of MH004 Ointment in Patients With Non-segmental Vitiligo (NCT07181187) | Minghui Pharmaceutical (Hangzhou) Ltd | 2024-03-26 |
| Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC) (NCT06149481) | National Cancer Institute (NCI) | 2024-03-26 |
| Imatinib TDM in GIST (NCT05493215) | Reema A. Patel | 2024-03-26 |
| Prophylaxis of Graft-versus-host Disease With Anti-CD25 Antibody in Patients Underwent HSCT (NCT06334367) | Wang Xin | 2024-03-26 |
| Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases (NCT06300463) | Weill Medical College of Cornell University | 2024-03-26 |
| A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL) (NCT06163430) | Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2024-03-26 |
| A Study of VRN110755 in Patients With EGFR-Mutant Non-Small Cell Lung Cancer (NCT07699328) | Voronoi, Inc | 2024-03-26 |
| CtDNA in Adjuvant Chemotherapy of Stage III Colon Cancer (REVISE Trial) (NCT06242418) | West China Hospital | 2024-03-25 |
| Effect of the PLAN CUIDARTE on the Caregiving Competence of People With Heart Failure (NCT06309875) | Universidad de la Sabana | 2024-03-25 |
| The Effect of Early Norepinephrine on Stroke Volume Index, Cardiac Index, Lactate, and Arterial Elastance in Pediatric Septic Shock (NCT06461390) | Indonesia University | 2024-03-25 |
| Efficacy of Pembrolizumab and Lenvatinib in Patients With Anaplastic Thyroid Cancer (NCT06374602) | Saint Petersburg State University, Russia | 2024-03-25 |
| Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients (NCT06119217) | Trishula Therapeutics, Inc. | 2024-03-25 |
| A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder (NCT06254612) | Sirtsei Pharmaceuticals, Inc. | 2024-03-25 |
| PD, PK, and Safety of ALTO-203 in Patients With MDD (NCT06391593) | Alto Neuroscience | 2024-03-25 |
| 18F-Fluciclovine PET/CT in Multiple Myeloma (NCT06103838) | National Cancer Institute (NCI) | 2024-03-25 |
| Evaluating the Effect of Tranexamic Acid on the Clinical Outcomes in Patients With Traumatic Brain Injury (NCT06330935) | Mansoura University | 2024-03-25 |
| Study of EGFR TKI in Patients With Advanced NSCLC Harbouring EGFR Mutations (NCT06062823) | National University Hospital, Singapore | 2024-03-25 |
| Study of the Rechallenge Concept in Patients With BRAF-positive Anaplastic Thyroid Cancer After Progression on Anti-BRAF Therapy (NCT06362694) | Saint Petersburg State University, Russia | 2024-03-25 |
| Mechanisms of Dupilumab in AERD (NCT05031455) | Scripps Clinic | 2024-03-25 |
| Purinostat Mesylate Combined With Pomalidomide Capsules and Low-dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma (NCT06484829) | Chengdu Zenitar Biomedical Technology Co., Ltd | 2024-03-25 |
| Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts (NCT05625633) | Western Institute for Veterans Research | 2024-03-25 |
| Evaluate the Efficacy and Safety of JMKX000623 in Participants With Diabetic Peripheral Neuropathic Pain (NCT06221241) | Jemincare | 2024-03-25 |
| A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratoses and Non-Melanoma Skin Cancers (NCT06409195) | DermBiont, Inc. | 2024-03-25 |
| A Study to Investigate the Safety and Efficacy of NeuroQ on Cognitive Function in Health Adults with Self-Reported Memory Problems (NCT06672094) | LifeSeasons Inc. | 2024-03-25 |
| A Chinese Herbal Medicine for IBS-C (NCT06319729) | Hong Kong Baptist University | 2024-03-25 |
| Tislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Clinically Node-negative Head and Neck Squamous Cell Carcinoma (NCT06323369) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2024-03-25 |
| Ustekinumab for Intestinal Behçet's Syndrome With Myelodysplastic Syndrome (NCT07582991) | Liu Tian | 2024-03-24 |
| A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 (ALKS 2680-201) (NCT06358950) | Alkermes, Inc. | 2024-03-24 |
| A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis(SAR). (NCT06315426) | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 2024-03-24 |
| Preventive Effect of Perinatal Oral Probiotic Supplementation (POPS) on Neonatal Jaundice (NCT06087874) | Chinese University of Hong Kong | 2024-03-23 |
| A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis (NCT06257875) | AbbVie | 2024-03-23 |
| Regulation of Affect and Physiology in Depression (NCT06345859) | University of Southern California | 2024-03-22 |
| A Study to Evaluate 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA) (NCT06222671) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2024-03-22 |
| A Study of GH21 Combined With Previous Target Therapy or Immunotherapy in Patients With Advanced Solid Tumors (NCT06322095) | Suzhou Genhouse Bio Co., Ltd. | 2024-03-22 |
| A Phase II, Single-arm, Multicenter, Prospective Study of Cardunolizumab in Recurrent or Metastatic Vulvar and Vaginal Cancer (NCT06292689) | Zhejiang Cancer Hospital | 2024-03-22 |
| Autologous and Donor-derived CD7 CAR-T Therapy in Refractory or Relapsed T-cell Malignancies (NCT06316427) | Beijing GoBroad Hospital | 2024-03-22 |
| Neoadjuvant Low-dose Immunotherapy in Locally Advanced MMR-deficient Colorectal Cancer (NCT07523763) | Blokhin's Russian Cancer Research Center | 2024-03-22 |
| Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors (NCT06380660) | Acerand Therapeutics (Shanghai) Limited | 2024-03-22 |
| Phase 2 Study of EDG-5506 in Children and Adolescents With Duchenne Muscular Dystrophy Previously Treated With Gene Therapy (NCT06100887) | Edgewise Therapeutics, Inc. | 2024-03-22 |
| Safety and Efficacy Study of NGGT001 in Bietti Crystalline Corneoretinal Dystrophy Subjects (NCT06706427) | NGGT (Suzhou) Biotechnology Co., Ltd. | 2024-03-21 |
| Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer (NCT06323460) | Ohio State University Comprehensive Cancer Center | 2024-03-21 |
| Dose-Expansion Modular Study To Explore the Safety, Tolerability, and Anti-tumor Activity of HER3- DXd Monotherapy and Combinations in Patients With Inoperable Advanced Breast Cancer (ABC) After Progression on T-DXd (NCT06298084) | Gustave Roussy, Cancer Campus, Grand Paris | 2024-03-21 |
| Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma (NCT06297226) | Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 2024-03-21 |
| Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis (NCT06205121) | Molecure S.A. | 2024-03-21 |
| Evaluation of Treatment by Glofitamab in Combination With Rituximab or Obinutuzumab Plus CHOP in Patients With RIchter Syndrome (NCT06186648) | French Innovative Leukemia Organisation | 2024-03-21 |
| A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial (NCT06069726) | Duke University | 2024-03-21 |
| CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma (NCT06101381) | University of Sao Paulo | 2024-03-21 |
| COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER (NCT05692024) | Massachusetts General Hospital | 2024-03-21 |
| Clemastine Fumarate in the Treatment of Neurodevelopmental Delays in Williams Syndrome (NCT06315699) | Qilu Hospital of Shandong University | 2024-03-20 |